AI assistant
Zero Candida Technologies Incorporated — Board/Management Information 2026
Apr 7, 2026
48252_rns_2026-04-06_bb8f9d02-adba-404b-a8dc-31db18aee1f5.pdf
Board/Management Information
Open in viewerOpens in your device viewer
FORM 51 – 102F3
MATERIAL CHANGE REPORT
-
Name and Address of Company
Zero Candida Technologies Inc.
c/o Tanya Markovich Law Corporation
Suite 500 – 666 Burrard Street
Vancouver, BC V6C 3P6 -
Date of Material Change
April 3, 2026 -
News Release
News releases dated April 3, 2026 was disseminated through Newswire and was filed under the Company’s profile on SEDAR+ (www.sedarplus.ca) on April 6, 2026. -
Summary of the Material Change
Mr. Igor Kostioutchenko resigned as Director of the Company.
5.1 Full Description of the Material Change
Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT; OTC: ZCTFF) and Israeli FemTech medical device start-up, wishes to advise that Mr. Igor Kostioutchenko has resigned as a director of the Company, effective immediately. The Board would like to thank him for his services to date.
5.2 Disclosure for Restructuring Transactions
N/A.
-
Reliance on subsection 7.1(2) of National Instrument 51 – 102
N/A -
Omitted Information
N/A -
Executive Officer
Eli Ben-Haroosh, CEO
Phone: +972-51-565-2355 -
Date of Report
April 6, 2026